Biocon profit decreases 4.10% in (Q3) FY 2020-21

Source

Team Infinities:

Biocon Limited NSE Symbol:BIOCON, BSE Security Code:532523 has declared its 3rd(third) quarter unaudited consolidated financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by Biocon Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
18.79 17.60 17.53 53.23 48.41
Calculated Revenue of Biocon Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
1.19 6.76%(Revenue Increase) 1.26 7.19%(Revenue Increase) 4.82 9.96%(Revenue Increase)

Revenue: Biocon Limited's financial report shows that the company's revenue increased by 6.76% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.1.19 billions, as the company posted revenue of Rs.18.79 billions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.17.60 billions.
The result also shows that the company's revenue increased by 7.19% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.1.26 billions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.17.53 billions.
The company also reported that its revenue increased by 9.96% in 9 months end(April, 2020 - December, 2020) for revenue increase of Rs.4.82 billions, since the company reported revenue of Rs.53.23 billions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.48.41 billions.

Gross Margin(%) Reported by Biocon Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
57.61 53.87 66.51 60.64 60.80
Calculated Gross Margin(%) of Biocon Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
3.73 6.93%(GM Increase) 8.90 13.38%(GM Decrease) 0.16 0.27%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 6.93% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 3.73% GM increase, as the company reported 57.61% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 53.87% GM.
The result also indicates, the company's GM decreased by 13.38% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 8.90% GM decrease; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 66.51% GM.
The company also reported that its GM decreased by 0.27% in 9 months end(April, 2020 - December, 2020) for 0.16% GM decrease, since the company reported 60.64% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 60.80% GM.

EBITDA Reported by Biocon Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
4.27 4.02 4.77 12.57 14.30
Calculated EBITDA of Biocon Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.25 6.22%(EBITDA Increase) 0.50 10.48%(EBITDA Decrease) 1.73 12.10%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 6.22% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.0.25 billion, as the company posted EBITDA of Rs.4.27 billions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.4.02 billions.
The result also shows that the company's EBITDA decreased by 10.48% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA decrease of Rs.0.50 billion; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.4.77 billions.
The company also reported that its EBITDA decreased by 12.10% in 9 months end(April, 2020 - December, 2020) for EBITDA decrease of Rs.1.73 billions, since the company reported EBITDA of Rs.12.57 billions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.14.30 billions.

Profit and Loss Reported by Biocon Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
1.87(Profit ) 1.95(Profit ) 2.30(Profit ) 5.50(Profit ) 7.12(Profit )
Calculated Profit and Loss of Biocon Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.08 4.10%(Profit Decrease) 0.43 18.70%(Profit Decrease) 1.62 22.75%(Profit Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 4.10% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit decrease of Rs.0.08 billion, as the company posted profit of Rs.1.87 billions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.1.95 billions.
The result also shows that the company's profit decreased by 18.70% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit decrease of Rs.0.43 billion; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.2.30 billions.
The company also reported that its profit decreased by 22.75% in 9 months end(April, 2020 - December, 2020) for profit decrease of Rs.1.62 billions, since the company reported profit of Rs.5.50 billions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.7.12 billions.

EPS Reported by Biocon Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
1.42 1.43 1.71 4.11 5.28
Calculated EPS of Biocon Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.01 0.70%(EPS Decrease) 0.29 16.96%(EPS Decrease) 1.17 22.16%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 0.70% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS decrease of Rs.0.01, as the company posted EPS of Rs.1.42; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.1.43.
The result also shows that the company's EPS decreased by 16.96% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS decrease of Rs.0.29; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.1.71.
The company also reported that its EPS decreased by 22.16% in 9 months end(April, 2020 - December, 2020) for EPS decrease of Rs.1.17, since the company reported EPS of Rs.4.11; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.5.28.

 


***All amounts are given in Billion Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.